{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:34:08Z","timestamp":1764732848249},"reference-count":33,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.11155","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T10:01:27Z","timestamp":1574935287000},"source":"Crossref","is-referenced-by-count":7,"title":["Status and prognostic nomogram of patients with Burkitt lymphoma"],"prefix":"10.3892","author":[{"given":"Jielun","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huo","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"key":"key20200714105858_b1-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A sarcoma involving the jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br J Surg"},{"key":"key20200714105858_b2-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0065-230X(08)60470-4","article-title":"The pathogenesis of Burkitt's lymphoma","volume":"55","author":"Magrath","year":"1990","journal-title":"Adv Cancer Res"},{"key":"key20200714105858_b3-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","article-title":"Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas","volume":"106","author":"Bellan","year":"2005","journal-title":"Blood"},{"key":"key20200714105858_b4-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/AHMT.S94170","article-title":"Burkitt lymphoma in adolescents and young adults: Management challenges","volume":"8","author":"Dozzo","year":"2016","journal-title":"Adolesc Health Med Ther"},{"key":"key20200714105858_b5-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1182\/blood-2012-12-475558","article-title":"Trends in survival of patients with Burkitt lymphoma\/leukemia in the USA: An analysis of 3691 cases","volume":"121","author":"Costa","year":"2013","journal-title":"Blood"},{"key":"key20200714105858_b6-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1002\/cncr.28264","article-title":"Population-based prognostic factors for survival in patients with Burkitt lymphoma: An analysis from the surveillance, epidemiology, and end results database","volume":"119","author":"Castillo","year":"2013","journal-title":"Cancer"},{"key":"key20200714105858_b7-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20200714105858_b8-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1200\/JCO.20.3.791","article-title":"Postoperative nomogram for 12-year sarcoma-specific death","volume":"20","author":"Kattan","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20200714105858_b9-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1200\/JCO.2005.05.3884","article-title":"Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer","volume":"24","author":"International Bladder Cancer Nomogram Consortium","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20200714105858_b10-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"S3107","DOI":"10.1002\/cncr.24352","article-title":"Nomograms for staging, prognosis, and predicting treatment outcomes","volume":"115","author":"Touijer","year":"2009","journal-title":"Cancer"},{"key":"key20200714105858_b11-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20200714105858_b12-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2796.2006.01677.x","article-title":"Interpreting trends in cancer patient survival","volume":"260","author":"Dickman","year":"2006","journal-title":"J Intern Med"},{"key":"key20200714105858_b13-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"},{"key":"key20200714105858_b14-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"84","DOI":"10.7196\/SAMJ.2018.v108i2.12441","article-title":"Burkitt's lymphoma: The prevalence of HIV\/AIDS and the outcome of treatment","volume":"108","author":"Hesseling","year":"2018","journal-title":"S Afr Med J"},{"key":"key20200714105858_b15-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF01703945","article-title":"The BFM-protocol for HIV-negative Burkitt's lymphomas and L3 ALL in adult patients: A high chance for cure","volume":"65","author":"Pees","year":"1992","journal-title":"Ann Hematol"},{"key":"key20200714105858_b16-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","article-title":"Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols","volume":"85","author":"Soussain","year":"1995","journal-title":"Blood"},{"key":"key20200714105858_b17-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"key":"key20200714105858_b18-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/cncr.20143","article-title":"Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: Final results of cancer and leukemia group B study 9251","volume":"100","author":"Rizzieri","year":"2004","journal-title":"Cancer"},{"key":"key20200714105858_b19-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/1042819031000141301","article-title":"Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: Preserved efficacy with decreased toxicity","volume":"45","author":"Lacasce","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"key20200714105858_b20-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/annonc\/mdh262","article-title":"Treatment of Burkitt's\/Burkitt-like lymphoma in adolescents and adults: A 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens","volume":"15","author":"Smeland","year":"2004","journal-title":"Ann Oncol"},{"key":"key20200714105858_b21-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2141.2004.05141.x","article-title":"High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults","volume":"126","author":"Di Nicola","year":"2004","journal-title":"Br J Haematol"},{"key":"key20200714105858_b22-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajh.21648","article-title":"Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): A comparison of two adapted BFM protocols","volume":"85","author":"Tauro","year":"2010","journal-title":"Am J Hematol"},{"key":"key20200714105858_b23-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Soci\u00e9t\u00e9 Fran\u00e7aise d'Oncologie P\u00e9diatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"key":"key20200714105858_b24-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","article-title":"Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: Results of the FAB\/LMB 96 international study","volume":"141","author":"Gerrard","year":"2008","journal-title":"Br J Haematol"},{"key":"key20200714105858_b25-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/cncr.21776","article-title":"Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia","volume":"106","author":"Thomas","year":"2006","journal-title":"Cancer"},{"key":"key20200714105858_b26-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1365-2141.2011.08947.x","article-title":"RD-CODOX-M\/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and \u2018unclassifiable\u2019 highly aggressive B-cell lymphoma","volume":"156","author":"Corazzelli","year":"2012","journal-title":"Br J Haematol"},{"key":"key20200714105858_b27-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ajh.22189","article-title":"Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma\/leukemia","volume":"87","author":"Todeschini","year":"2012","journal-title":"Am J Hematol"},{"key":"key20200714105858_b28-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: Results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"key":"key20200714105858_b29-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","article-title":"Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20200714105858_b30-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1200\/JCO.1990.8.4.615","article-title":"Small noncleaved cell lymphoma in adults: Superior results for stages I\u2013III disease","volume":"8","author":"Lopez","year":"1990","journal-title":"J Clin Oncol"},{"key":"key20200714105858_b31-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.1996.14.1.240","article-title":"Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte","volume":"14","author":"Divin\u00e9","year":"1996","journal-title":"J Clin Oncol"},{"key":"key20200714105858_b32-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2147\/CMAR.S187522","article-title":"Clinical features and prognostic factors of primary bone marrow lymphoma","volume":"11","author":"Wang","year":"2019","journal-title":"Cancer Manag Res"},{"key":"key20200714105858_b33-ol-0-0-11155","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrneurol.2013.83","article-title":"Diagnosis and treatment of primary CNS lymphoma","volume":"9","author":"Korfel","year":"2013","journal-title":"Nat Rev Neurol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T10:14:24Z","timestamp":1594721664000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.11155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":33,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.11155","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]}}}